對于全球數(shù)百萬終末期腎病患者而言至關(guān)重要的血路管，由貝恩醫(yī)療設備（湖南）有限公司大量生產(chǎn),。這幾天,，公司正在趕阿根廷、巴西,、瑞士,、越南等國家的訂單。

Blood tubing, which is crucial for millions of end-stage renal disease patients worldwide, is mass-produced by Bain Medical Equipment (Hunan) Co., Ltd. These days, the company is rushing to fulfill orders from countries such as Argentina, Brazil, Switzerland, and Vietnam.

貝恩醫(yī)療位于中國瀏陽市,，其生產(chǎn)車間的生產(chǎn)線晝夜運轉(zhuǎn),，每天制造18萬套血路管，其中6萬套銷往海外,，產(chǎn)品訂單爆滿,、供不應求。作為國家高新技術(shù)企業(yè),，公司堅持自主創(chuàng)新,，自研先進的全自動化生產(chǎn)線，產(chǎn)品科技含量高,，在血路管生產(chǎn)領(lǐng)域成績斐然,。

Located in Liuyang City, China, the production lines in Bain Medical's workshops operate around the clock. They manufacture 180,000 sets of blood tubing every day, with 60,000 sets being sold overseas. The products are so popular that there are overwhelming orders and the supply cannot meet the demand. As a national high-tech enterprise, the company adheres to independent innovation and has developed advanced fully-automated production lines on its own. Its products are highly technological and have achieved remarkable results in the field of blood tubing production.

作為湘商回歸項目，其落戶瀏陽既源于創(chuàng)始人的家鄉(xiāng)情結(jié),，也得益于當?shù)亓己玫臓I商環(huán)境,。2022年簽約投產(chǎn)，2024年中南總部項目建成,，2023年瀏陽生產(chǎn)基地產(chǎn)值4.92億元,、創(chuàng)稅超3000萬元，目前公司考慮擴建增產(chǎn),，當?shù)卣畬⑷χС帧?/p>

As a project of Hunan-born entrepreneurs returning home, its settlement in Liuyang is not only due to the founder's hometown complex but also benefits from the local favorable business environment. It signed the contract and started production in 2022, and the Central South Headquarters project was completed in 2024. In 2023, the Liuyang production base had an output value of 492 million yuan and paid more than 30 million yuan in taxes. Currently, the company is considering expansion and production increase, and the local government will fully support it.